Healthpeak Properties (DOC) Earnings Analysis
Healthpeak Properties (DOC) has no confirmed upcoming earnings date. Last quarter (2026-02-02) it beat with EPS 0.47 USD vs 0.45 USD est (+4.4%). It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E 70.36.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does DOC next report earnings?
No confirmed upcoming earnings date is currently scheduled for DOC. This page updates as the calendar is published.
DOC earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-02 | 0.47 USD | 0.45 USD | +4.4% | Beat |
| 2025-10-23 | 0.46 USD | 0.45 USD | +2.2% | Beat |
| 2025-07-24 | 0.46 USD | 0.46 USD | 0% | Beat |
| 2025-04-24 | 0.46 USD | 0.46 USD | 0% | Beat |
| 2025-02-03 | 0.46 USD | 0.05 USD | +820% | Beat |
| 2024-10-24 | 0.45 USD | 0.44 USD | +2.3% | Beat |
| 2024-07-25 | 0.45 USD | 0.44 USD | +2.3% | Beat |
Beat rate: 7/7 (100%) over reported quarters with consensus data.
DOC valuation and analyst view
| Trailing P/E | 70.36 |
|---|---|
| Trailing EPS | 0.31957 USD |
| Price / book | 1.97 |
| Dividend yield | 5.50% |
| Market cap | 15.36B |
| Analyst consensus | Buy (21 buy / 20 hold / 0 sell) |
| Avg price target | 21.44 USD |
Related research pages
Frequently asked questions
When is Healthpeak Properties (DOC)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for DOC. This page updates as the calendar is published.
Did DOC beat earnings last quarter?
In its 2026-02-02 report, DOC posted EPS of 0.47 USD versus a 0.45 USD estimate — a beat of 4.4%.
What is DOC's earnings track record?
Over the last 7 reported quarters with consensus data, DOC beat estimates 7 times (100%).
What is DOC's current P/E ratio and EPS?
DOC trades at a trailing P/E of 70.36 on trailing EPS of 0.3195691357829337 USD.
What do analysts rate DOC?
Analyst consensus is "Buy" across 41 ratings (0 strong buy, 21 buy, 20 hold, 0 sell, 0 strong sell). Average 12-month price target: 21.44 USD.